ACTON, Mass.--(BUSINESS WIRE)--Neuroptix Corporation, a Massachusetts-based pioneer in the early detection of Alzheimer’s disease, today announced that the successful diagnostics executive Dr. Werner Schaefer has joined the company’s Board of Directors.
